| AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ... Nature communications 10 (1), 3094, 2019 | 225 | 2019 |
| Type 2 diabetes as a determinant of Parkinson's disease risk and progression H Chohan, K Senkevich, RK Patel, JP Bestwick, BM Jacobs, ... Movement disorders 36 (6), 1420-1429, 2021 | 172 | 2021 |
| Autophagy lysosomal pathway dysfunction in Parkinson's disease; evidence from human genetics K Senkevich, Z Gan-Or Parkinsonism & related disorders 73, 60-71, 2020 | 116 | 2020 |
| Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson’s disease S Pchelina, A Emelyanov, G Baydakova, P Andoskin, K Senkevich, ... Neuroscience letters 636, 70-76, 2017 | 95 | 2017 |
| Relevance of biomarkers across different neurodegenerative diseases AJ Ehrenberg, A Khatun, E Coomans, MJ Betts, F Capraro, EH Thijssen, ... Alzheimer's research & therapy 12, 1-11, 2020 | 83 | 2020 |
| PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation V Chelban, MP Wilson, J Warman Chardon, J Vandrovcova, MN Zanetti, ... Annals of neurology 86 (2), 225-240, 2019 | 73 | 2019 |
| New therapeutic approaches to Parkinson's disease targeting GBA, LRRK2 and Parkin K Senkevich, U Rudakou, Z Gan-Or Neuropharmacology 202, 108822, 2022 | 66 | 2022 |
| Mutation analysis of Parkinson's disease genes in a Russian data set AK Emelyanov, TS Usenko, C Tesson, KA Senkevich, MA Nikolaev, ... Neurobiology of Aging 71, 267. e7-267. e10, 2018 | 60 | 2018 |
| Blood lysosphingolipids accumulation in patients with parkinson's disease with glucocerebrosidase 1 mutations S Pchelina, G Baydakova, M Nikolaev, K Senkevich, A Emelyanov, ... Movement disorders 33 (8), 1325-1330, 2018 | 59 | 2018 |
| Fine mapping of the HLA locus in Parkinson’s disease in Europeans E Yu, A Ambati, MS Andersen, L Krohn, MA Estiar, P Saini, K Senkevich, ... npj Parkinson's Disease 7 (1), 84, 2021 | 56 | 2021 |
| Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects L Krohn, K Heilbron, C Blauwendraat, RH Reynolds, E Yu, K Senkevich, ... Nature communications 13 (1), 7496, 2022 | 49 | 2022 |
| Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism AE Kopytova, GN Rychkov, MA Nikolaev, GV Baydakova, AA Cheblokov, ... Parkinsonism & related disorders 84, 112-121, 2021 | 48 | 2021 |
| Neurofilament light levels predict clinical progression and death in multiple system atrophy V Chelban, E Nikram, A Perez-Soriano, C Wilke, A Foubert-Samier, ... Brain 145 (12), 4398-4408, 2022 | 35 | 2022 |
| Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and … P Obrocki, A Khatun, D Ness, K Senkevich, J Hanrieder, F Capraro, ... Alzheimer's Research & Therapy 12, 1-10, 2020 | 35 | 2020 |
| Plasma cytokines profile in patients with Parkinson’s disease associated with mutations in GBA gene IV Miliukhina, TS Usenko, KA Senkevich, MA Nikolaev, AA Timofeeva, ... Bulletin of Experimental Biology and Medicine 168, 423-426, 2020 | 32 | 2020 |
| Plasma cytokine profile in synucleinophaties with dementia TS Usenko, MA Nikolaev, IV Miliukhina, AI Bezrukova, KA Senkevich, ... Journal of Clinical Neuroscience 78, 323-326, 2020 | 29 | 2020 |
| SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson’s disease A Emelyanov, D Kulabukhova, L Garaeva, K Senkevich, E Verbitskaya, ... Journal of the neurological sciences 395, 135-140, 2018 | 23 | 2018 |
| GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease K Senkevich, CE Zorca, A Dworkind, U Rudakou, E Somerville, E Yu, ... Brain 146 (5), 1859-1872, 2023 | 20 | 2023 |
| LRRK2 p. M1646T is associated with glucocerebrosidase activity and with Parkinson's disease YL Sosero, E Yu, L Krohn, U Rudakou, K Mufti, JA Ruskey, F Asayesh, ... Neurobiology of aging 103, 142. e1-142. e5, 2021 | 20 | 2021 |
| The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons J Jones-Tabah, K He, N Karpilovsky, K Senkevich, G Deyab, ... Molecular neurodegeneration 19 (1), 88, 2024 | 17 | 2024 |
Ziv Gan-OrAssociate Professor, The Neuro (Montreal Neurological Institute-Hospital), McGill UniversityEmail yang diverifikasi di mcgill.ca